Skip to content
2000
Volume 4, Issue 6
  • ISSN: 1568-0096
  • E-ISSN: 1873-5576

Abstract

Heparin affin regulatory peptide (HARP), also known as pleiotrophin or heparin-binding growthassociated molecule, is an 18-kDa growth factor that has a high affinity for heparin. It constitutes with midkine and retinoic acid heparin-binding protein, a family of structurally related heparin-binding growth factors. A growing body of evidence indicates that HARP is involved in the control of cellular proliferation, migration and differentiation and plays a significant role in tumor growth and angiogenesis. HARP has a well described role in physiological as well as tumor angiogenesis, and is detected in various carcinomas, such as human breast and prostate cancer, neuroblastomas, gliomas, benign meningiomas, small cell lung cancer and mammary tumors, exhibiting a proto-oncogene function. It is also constitutively expressed in tumour cell lines and is involved in tumour growth and metastasis. Therefore, HARP appears to be a potential new target for the treatment or / and diagnosis of several types of cancer.

Loading

Article metrics loading...

/content/journals/ccdt/10.2174/1568009043332835
2004-09-01
2025-05-24
Loading full text...

Full text loading...

/content/journals/ccdt/10.2174/1568009043332835
Loading

  • Article Type:
    Review Article
Keyword(s): angiogenesis; cancer; growth factors; heparin affin regulatory peptide; pleiotrophin
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test